ArticleJAAD case reports2026

The dose matters: Oral tofacitinib dose escalation or switching to deuruxolitinib for recalcitrant alopecia universalis and totalis, a retrospective case series.

Raymond Z Ezzat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.